Trials / Completed
CompletedNCT04060446
Effects of Filter Ventilation on Sensory Response, Smoking Topography, and Inhalation in Current Every Day Cigarette Smokers
Effects of Filter Ventilation on Sensory Response, Smoking Topography, and Inhalation (COMET 2 2.1)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 8 (actual)
- Sponsor
- Roswell Park Cancer Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 69 Years
- Healthy volunteers
- Accepted
Summary
This trial examines the effects of filter ventilation on sensory response, smoking topography, and inhalation in current every day cigarette smokers. The physical design features of cigarettes directly impact their appeal by influencing cognitive and sensory perceptions. The introduction of a now common design feature, filter ventilation, has led to greater public harm than benefit because of the potential for greater toxicity while enhancing product appeal among smokers. Ventilated cigarettes dilute smoke, which promotes perceptions of ?smoothness? and therefore lower health risk, contributing to the overall appeal of these products. The purpose of this study is to assess whether removing ventilation from cigarette filters lowers cigarette product appeal among smokers.
Detailed description
PRIMARY OBJECTIVES: I. To assess the link between marketing proxies for filter ventilation (product descriptors, packaging) and risk beliefs. OUTLINE: Patients smoke 5 cigarettes separated by 30 minute washout periods. Between 48 hours and 1 week later, patients smoke another 5 cigarettes separated by 30 minute washout period with CReSSMicro topography measurement device and BioRadio device for recording inhalation patterns.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Medical Device | Smoke cigarettes with CReSSMicro topography measurement device and BioRadio device |
| OTHER | Questionnaire Administration | Ancillary studies |
| BEHAVIORAL | Tobacco Smoking | Smoke cigarettes |
Timeline
- Start date
- 2019-06-06
- Primary completion
- 2020-03-02
- Completion
- 2020-03-02
- First posted
- 2019-08-19
- Last updated
- 2022-07-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04060446. Inclusion in this directory is not an endorsement.